Latest News about Pharmaceuticals
Recent news which mentions Pharmaceuticals
FDA says Eli Lilly's weight loss drug Zepbound is no longer in shortage
December 19, 2024
From CNBC.com News
Why Americans are outraged over health insurance — and what could change
December 18, 2024
From CNBC.com News
Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
December 18, 2024
From CNBC.com News
UnitedHealth Group CEO addresses Brian Thompson death, says healthcare system is 'flawed'
December 13, 2024
From CNBC.com News
From Benzinga
Health care stocks fall as lawmakers, patients push for changes to their business models
December 11, 2024
From CNBC.com News
Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly
December 11, 2024
From CNBC.com News
Insurance stocks have fallen since UnitedHealthcare CEO's killing
December 10, 2024
From CNBC.com News
Eli Lilly's $15 Billion Buyback Faces Stiff Resistance On The Charts
December 10, 2024
Tickers
LLY
From Benzinga
The weight-loss drug boom has become one of the internet's biggest scams
December 08, 2024
From CNBC.com News
Executives seek more protection after UnitedHealthcare CEO Thompson killing, Kroll says
December 05, 2024
From CNBC.com News
Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
December 05, 2024
From CNBC.com News
Stock Of The Day: Where Will The Eli Lilly Rally End?
December 04, 2024
From Benzinga
Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial
December 04, 2024
From CNBC.com News
CDC says McDonald's E. coli outbreak is over
December 03, 2024
From CNBC.com News
Bristol-Myers Squibb Files Lawsuit Against US Agency For Overreach In 340B Drug Pricing Program
November 29, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.